Avantor Investor Conference Presentation Deck
Innovation enhances growth and resilience
INSIGHTS
13
global innovation
centers
More than
300K
customer locations
using Avantor products
Navantor
INNOVATION
1,500+
active customer-requested
R&D projects
Investing
MSD
in innovation as % of
self-manufactured sales ²
SPECIFICATIONS
3X
growth in annual
bioproduction revenue
from NPIs³
Specified into
85%
of top 20
biologic drugs4
1. Active R&D projects tied to specific customer opportunity.
2.
Includes all R&D personnel, innovation center expenses and other R&D spend as a % of self-
manufactured proprietary revenue.
3. Represents growth in total bioproduction revenues from NPIs from 2020 to 2022E.
4. 2022 data from Evaluate Pharma.
NPI EXAMPLES
1 2 3
Viral inactivation for
Monoclonal Antibodies
Cell lysis
for Cell & Gene therapy
Synthetic lipids
for mRNA
41st Annual J.P. Morgan Healthcare Conference
13View entire presentation